Select a medication above to begin.
Relacorilant
relacorilant
Adult Dosing .
Dosage forms: CAP: 100 mg
Investigational New Drug (IND)
- [pending FDA approval]
Cushing syndrome
- [indication/pt population pending FDA approval]
- Info: competitively antagonizes cortisol activity w/ no affinity for progesterone receptor (selective glucocorticoid receptor modulator)
Peds Dosing .
- Dosage forms: --
Investigational New Drug (IND)
- [pending FDA approval]
- Info: not anticipated to be applicable to Peds population